Therapy of cutaneous lymphoma -: Current practice and future developments

被引：26

作者：

Dummer, R ^{[1
]}

Kempf, W ^{[1
]}

Schmid, MH ^{[1
]}

Häffner, A ^{[1
]}

Burg, G ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland

来源：

ONKOLOGIE | 2003年 / 26卷 / 04期

关键词：

cutaneous lymphomas; B-cell lymphomas; cutaneous; T-cell lymphomas; Sezary syndrome; mycosis fungoides;

D O I：

10.1159/000072098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cutaneous lymphomas include various types of clonal lymphoproliferative disorders. The adequate treatment approach depends on the exact diagnosis and should be non-aggressive in most cases. In early stages, local approaches such as UV or radiotherapy are preferred. In advanced stages, systemic drugs such as interferon-a or bexarotene can be administered. Experimental approaches for cutaneous lymphomas include vaccination and gene therapy.

引用

页码：366 / 372

页数：7

共 79 条

[1]

[Anonymous], MODERN DERMATOLOGIC

[2] Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment [J].

Bekkenk, MW ;

Geelen, FAMJ ;

Vader, PCV ;

Heule, F ;

Geerts, ML ;

van Vloten, WA ;

Meijer, CJLM ;

Willemze, R .

BLOOD, 2000, 95 (12) :3653-3661

[3] Treatment of multifocal primary cutaneous B-cell lymphoma: A clinical follow-up study of 29 patients [J].

Bekkenk, MW ;

Vermeer, MH ;

Geerts, ML ;

Noordijk, EM ;

Heule, F ;

Vader, PCV ;

van Vloten, WA ;

Meijer, CJLM ;

Willemze, R .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2471-2478

[4] Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas - A distinct clinicopathological entity with an aggressive clinical behavior [J].

Berti, E ;

Tomasini, D ;

Vermeer, MH ;

Meijer, CJLM ;

Alessi, E ;

Willemze, R .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :483-492

[5] RETICULOHISTIOCYTOMA OF THE DORSUM [J].

BERTI, E ;

ALESSI, E ;

CAPUTO, R ;

GIANOTTI, R ;

DELIA, D ;

VEZZONI, P .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (02) :259-272

[6] LYMPHOMATOID PAPULOSIS - CLINICAL IMPROVEMENT AFTER PUVA-THERAPY [J].

BLONDEEL, A ;

KNITELIUS, AC ;

DECONINCK, A ;

DEDOBBELEER, G ;

ACHTEN, G .

DERMATOLOGICA, 1982, 165 (05) :466-468

[7] Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma [J].

Breneman, D ;

Duvic, M ;

Kuzel, T ;

Yocum, R ;

Truglia, J ;

Stevens, VJ .

ARCHIVES OF DERMATOLOGY, 2002, 138 (03) :325-332

[8] SYSTEMIC THERAPY OF CUTANEOUS T-CELL LYMPHOMAS (MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME) [J].

BUNN, PA ;

HOFFMAN, SJ ;

NORRIS, D ;

GOLITZ, LE ;

AELING, JL .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (08) :592-602

[9]

BUNN PA, 1979, CANCER TREAT REP, V63, P725

[10] SEMIMALIGNANT (PSEUDOLYMPHOMATOUS) CUTANEOUS B-CELL LYMPHOMAS [J].

BURG, G ;

SCHMID, MH ;

KUNG, E ;

DOMMANN, S ;

DUMMER, R .

DERMATOLOGIC CLINICS, 1994, 12 (02) :399-407

← 1 2 3 4 5 6 7 8 →